Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 30 (RPL35AP30)

Target: RPL35AP30
Molecular classification: Other (Pseudogene)

Overview

RPL35AP30 (ribosomal protein L35a pseudogene 30) is a human processed pseudogene formed by retrotransposition and is related to the functional RPL35A gene, which encodes a ribosomal protein component of the 60S subunit involved in protein synthesis. Unlike its functional counterpart, RPL35AP30 does not encode a functional protein, is not expressed as a protein, and has no established biological or therapeutic function[1][3][4]. Pseudogenes like RPL35AP30 are generally non-functional remnants in the genome and are not used as therapeutic targets in medicine.

Other names: RPL35AP30RPL35A_17_1286RPL35AP30 (alternative catalog entries)

Biological functions

Other (none established)

Disease associations

Other (none known)

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 30 (RPL35AP30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 30 (RPL35AP30).

Explore the full profile